Hergen Spits

Immunology and Microbiology · Life Sciences

109h-index51.0kcitations502works7.62yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(222), T-cell and B-cell Immunology(192), Immunotherapy and Immune Responses(120), IL-33, ST2, and ILC Pathways(94), Monoclonal and Polyclonal Antibodies Research(86)

Publications500 total

Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response
Immunity·2025· 1 citedOpen Access
Long-Lasting AML-Specific Antibody Responses after Allogeneic Hematopoietic Progenitor Cell Transplantation
Blood·2024Open Access
Allergen‐specific B cell responses in oral immunotherapy‐induced desensitization, remission, and natural outgrowth in cow's milk allergy
Allergy·2024· 15 citedOpen Access
Human CD127 negative ILC2s show immunological memory
The Journal of Experimental Medicine·2024· 19 citedOpen Access
Cytolytic too: Granzyme B-expressing human ILC2s mediate tumor rejection
Cell Research·2024· 3 citedOpen Access
Human CD127 negative ILC2s show immunological memory
2023· 3 citedOpen Access
Inflammatory innate lymphoid cells predict response speed to dupilumab in chronic rhinosinusitis with nasal polyps
Allergy·2023· 12 citedOpen Access
OP0104 NON-CANONICAL NF-ΚB SIGNALLING IS REQUIRED FOR EXTRATHYMIC AIRE EXPRESSION AND IMMUNOREGULATORY MOLECULES IN CELLS OF THE DENDRITIC LINEAGE
2023Open Access
Data from Effective Inhibition of Bone Morphogenetic Protein Function by Highly Specific Llama-Derived Antibodies
2023Open Access
Figure S1 from Effective Inhibition of Bone Morphogenetic Protein Function by Highly Specific Llama-Derived Antibodies
2023Open Access
Data from Effective Inhibition of Bone Morphogenetic Protein Function by Highly Specific Llama-Derived Antibodies
2023Open Access
Figure S5 from Effective Inhibition of Bone Morphogenetic Protein Function by Highly Specific Llama-Derived Antibodies
2023Open Access
Figure S3 from Effective Inhibition of Bone Morphogenetic Protein Function by Highly Specific Llama-Derived Antibodies
2023Open Access
Figure S4 from Effective Inhibition of Bone Morphogenetic Protein Function by Highly Specific Llama-Derived Antibodies
2023Open Access
Table S1 from Effective Inhibition of Bone Morphogenetic Protein Function by Highly Specific Llama-Derived Antibodies
2023Open Access
Figure S5 from Effective Inhibition of Bone Morphogenetic Protein Function by Highly Specific Llama-Derived Antibodies
2023Open Access
Figure S1 from Effective Inhibition of Bone Morphogenetic Protein Function by Highly Specific Llama-Derived Antibodies
2023Open Access
Table S1 from Effective Inhibition of Bone Morphogenetic Protein Function by Highly Specific Llama-Derived Antibodies
2023Open Access
Figure S2 from Effective Inhibition of Bone Morphogenetic Protein Function by Highly Specific Llama-Derived Antibodies
2023Open Access
Figure S2 from Effective Inhibition of Bone Morphogenetic Protein Function by Highly Specific Llama-Derived Antibodies
2023Open Access
page 1 of 25Next →

Frequent Co-authors

Hans Yssel(6), J E de Vries(6), Jochem H. Bernink(6), James P. Di Santo(5), Jenny Mjösberg(5), Kees Weijer(5), Andrew N. J. McKenzie(4), René de Waal Malefyt(4), John B.A.G. Haanen(4), Natasha K. Crellin(4), Arjen Q. Bakker(4), Bianca Blom(4), David Artis(3), Andreas Diefenbach(3), Gérard Eberl(3), Éric Vivier(3), Sara Trifari(3), Charlotte P. Peters(3), Cornelis M. van Drunen(3), Tom Cupedo(3)